Larimar Therapeutics recently completed an upsized US$100,000,000 follow-on equity offering at US$5.00 per share, shortly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results